Internal Neuromodulation Devices Market by Product, End User, Application and Region – Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2029
8.6%
CAGR (2022-2029)
6.32 USD Bn.
Market Size
328
Report Pages
137
Market Tables
Overview
Internal Neuromodulation Devices Market is expected to reach US$ 12.24 Bn. at a CAGR of 8.6 during the forecast period 2029.
Neuromodulation devices are among the fastest-growing areas of medicine, involving many diverse specialists and impacting hundreds of thousands of patients with numerous disorders worldwide. Neuromodulation devices have played an increasing role in the treatment algorithm for patients with chronic pain. These devices are strategically aiming to reduce the unpleasant sensory experience of pain and consequent functional and behavioral effects that pain may have.
To know about the Research Methodology :- Request Free Sample Report
In Global Internal Neuromodulation Devices Market segmentation by product type, application, end-user, and region, the report covers major key players are Medtronic plc, LivaNova PLC, Cyberonics, Inc., St. Jude Medical Inc., Boston Scientific Corporation, EnteroMedics Inc, BioControl Medical, Bioness Inc., Nevro Corporation, and NeuroPace Inc.
The research report on the Global Internal Neuromodulation Devices market is a compilation of intelligent, broad studies research with a detail annual study of key players and stakeholders. It gives precise and reliable suggestions for players to better address challenges inside the global internal neuromodulation devices market. The report comes out as a powerful resource providing up to date and verified information and records on numerous aspects of the global internal neuromodulation devices market. The report has been compiled through giant primary studies (through interviews, surveys, and observations of pro analysts) and secondary research. The report also features a whole qualitative and quantitative assessment by way of analyzing facts from industry analysts and market participants across key points.
Internal Neuromodulation Devices Market Dynamics
The treatment with neuromodulation devices delivered the facilities that can offer comprehensive assessments and a range of additional physical and psychological pain management options, which help to cure patients in an effective way. Ongoing research & development in the healthcare sector especially in neuromodulation devices and high healthcare awareness helps to drive the global market during forecast period. The global internal neuromodulation devices market is expected to expand due to growing safety awareness and efficacy of these devices. On the other hand, increasing neurological disorders prevalence and increasing number of clinical trials, globally, for the progress of innovative technologies are helping to boost the global market growth during forecast period.
Internal Neuromodulation Devices Market - Segmentation
Spinal cord stimulation (SCS) is dominating the segment, as it is minimally invasive, safe, and a reversible treatment modality with limited side effect profile.
The current prevalence of patients with chronic pain requiring treatment other than conventional medical management has significantly increased and so has been the need for Spinal Cord Stimulator.
A spinal Cord Stimulator is an essential device of the treatment algorithm for patients suffering from neuropathic pain. Spinal Cord Stimulator is a reversible, minimally invasive approach to treat pain that has goals of reducing, suffering, improving function, reducing health care utilization, reducing opioid use, and improving quality of life. SCS is an efficacious, cost-effective option that should be used much earlier in the treatment continuum in many disease states, including lumbar and cervical radiculopathy, failed back surgery syndrome, peripheral neuropathy, ischemic pain, and complex regional pain syndrome.
SCS has shown that it is the best product to improve blood flow, improve tissue oxygenation, and enhanced wound healing. Hence it is used in patients who have either severe ischemic pain or mixed pain of both ischemic and neuropathic origin.
Parkinson’s disease held the largest share of the global internal neuromodulation devices market during forecast period 2021-2029.
Neuromodulation devices used to help patients with Parkinson's disease symptoms. People with Parkinson’s who do not respond well to medications, use deep brain stimulator a neuromodulator device, which help in mostly all surgical procedure that stimulates the brain in a way that helps stop many of the movement-related symptoms of Parkinson's, such as tremor, slowness of movement, and rigidity. Neuromodulation devices include physical, occupational, and speech therapies, which help with gait and voice disorders, tremors and rigidity, and decline in mental functions. The internal neuromodulation devices also help to strengthen muscles and improve balance. As a result, Parkinson’s disease segment is expected to command the largest market share of xx% by 2029.
Introduction of basic general medical training program and establishment of dispensaries at sub-division and district level at the hospital, drive hospital segment during the forecast period. Availability of health service to all citizens, irrespective of their ability to pay for it and it should be complete medical service, in which all the facilities required for the treatment and prevention of disease as well as for the promotion of positive health care provided. Governments across the globe have the main focus on higher education, research, and national health programs, for example, family welfare, primary health care, and prevention, control, and eradication of major diseases which form the main plank of development efforts in Global Internal Neuromodulation Devices Market. The Department of Health has made strategic interventions to ensure more vigorous implementation and to improve the effectiveness of different global Health Programmes aimed at combating communicable and non-communicable diseases. Global government hospitals to raise the quality of their services, introduce transparency and accountability, and provide services with courtesy and efficiency to the patient. Hence this all factors are expected to command the largest market share of xx% from 2021 to 2029.
Europe is expected to command largest global internal neuromodulation devices market share of xx% with USD xx Mn growth in the forecast period of 2021 to 2029.
Public and private organizations from Europe are taking initiatives to increase awareness of growing neurological disorders and the growth of the mental health market
The use of internal neuromodulation devices with recent technological innovations drive the global market from North America. The rise in the number of patients with neurological disorders and problems occurring due to accidents, trauma, hypertension, and hectic lifestyle is anticipated to drive the global internal neuromodulation devices market in this region. Preference for minimally invasive procedures like deep brain stimulators, spinal cord simulators by doctors & professionals is helping to grow the global market from Europe.
Scope of Global Internal Neuromodulation Devices Market: Inquire before buying
| Global Internal Neuromodulation Devices Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2021 | Forecast Period: | 2022-2029 |
| Historical Data: | 2017 to 2021 | Market Size in 2021: | US $ 6.32 Bn. |
| Forecast Period 2022 to 2029 CAGR: | 8.6% | Market Size in 2029: | US $ 12.24 Bn. |
| Segments Covered: | by Product | • Deep brain stimulators • Sacral nerve stimulators • Vagus nerve stimulators • Spinal cord stimulators • Other internal neuromodulation devices |
|
| by End User | • Hospitals • Clinics • Home healthcare |
||
| by Application | • Failed back syndrome • Tremors • Epilepsy • Chronic pain management • Parkinson’s disease • Depression • Urinary and fecal incontinence • Gastroparesis • Migraine • Obsessive-compulsive disorder • Others |
||
Internal Neuromodulation Devices Market, by Region
• North America
• Europe
• Asia-Pacific
• MEA & Africa
• Latin America
Internal Neuromodulation Devices Market Key Players are:
• Medtronic plc
• LivaNova PLC
• Cyberonics Inc.
• St. Jude Medical Inc.
• Boston Scientific Corporation
• EnteroMedics Inc
• BioControl Medical
• Bioness Inc.
• Nevro Corporation
• NeuroPace Inc.
• Abbott
• Synapse Biomedical
• Neurosigma
• Neuronetics
• Soterix Medical
• Integer Holdings Corporation
• Bioinduction
• GiMer Medical
• GTX Medical
• Helius Medical Technologies
• Micro transponder
• Neuronano
• Bluewind
Frequently Asked questions
1. What is the market size of the Global Internal Neuromodulation Devices Market in 2021?
Ans. The market size Global Internal Neuromodulation Devices Market in 2021 was US$ 6.32 Billion.
2. What are the different segments of the Global Internal Neuromodulation Devices Market?
Ans. The Global Internal Neuromodulation Devices Market is divided into Product, Application and End User.
3. What is the study period of this market?
Ans. The Global Internal Neuromodulation Devices Market will be studied from 2021 to 2029.
4. Which region is expected to hold the highest Global Internal Neuromodulation Devices Market share?
Ans. The Asia Pacific dominates the market share in the market.
5. What is the Forecast Period of Global Internal Neuromodulation Devices Market?
Ans. The Forecast Period of the market is 2022-2029 in the market.
Table of Contents
Global Internal Neuromodulation Devices Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Internal Neuromodulation Devices Market Size, By Market Value (US$ Mn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global Internal Neuromodulation Devices Market Analysis and Forecast
6.1. Internal Neuromodulation Devices Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Internal Neuromodulation Devices Market Analysis and Forecast, By Product Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Internal Neuromodulation Devices Market Value Share Analysis, By Product Type
7.4. Internal Neuromodulation Devices Market Size (US$ Mn) Forecast, By Product Type
7.5. Internal Neuromodulation Devices Market Analysis, By Product Type
7.6. Internal Neuromodulation Devices Market Attractiveness Analysis, By Product Type
8. Global Internal Neuromodulation Devices Market Analysis and Forecast, By Application
8.1. Introduction and Definition
8.2. Key Findings
8.3. Internal Neuromodulation Devices Market Value Share Analysis, By Application
8.4. Internal Neuromodulation Devices Market Size (US$ Mn) Forecast, By Application
8.5. Internal Neuromodulation Devices Market Analysis, By Application
8.6. Internal Neuromodulation Devices Market Attractiveness Analysis, By Application
9. Global Internal Neuromodulation Devices Market Analysis and Forecast By End User
9.1. Introduction and Definition
9.2. Key Findings
9.3. Internal Neuromodulation Devices Market Value Share Analysis, By End User
9.4. Internal Neuromodulation Devices Market Size (US$ Mn) Forecast, By End User
9.5. Internal Neuromodulation Devices Market Analysis, By End User
9.6. Internal Neuromodulation Devices Market Attractiveness Analysis, By End User
10. Global Internal Neuromodulation Devices Market Analysis, By Region
10.1. Internal Neuromodulation Devices Market Value Share Analysis, By Region
10.2. Internal Neuromodulation Devices Market Size (US$ Mn) Forecast, By Region
10.3. Internal Neuromodulation Devices Market Attractiveness Analysis, By Region
11. North America Internal Neuromodulation Devices Market Analysis
11.1. Key Findings
11.2. North America Internal Neuromodulation Devices Market Overview
11.3. North America Internal Neuromodulation Devices Market Value Share Analysis, By Product Type
11.4. North America Internal Neuromodulation Devices Market Forecast, By Product Type
11.4.1. Deep brain stimulators
11.4.2. Sacral nerve stimulators
11.4.3. Vagus nerve stimulators
11.4.4. Spinal cord stimulators
11.4.5. Other internal neuromodulation devices
11.5. North America Internal Neuromodulation Devices Market Value Share Analysis, By Application
11.6. North America Internal Neuromodulation Devices Market Forecast, By Application
11.6.1. Failed back syndrome
11.6.2. Tremors
11.6.3. Epilepsy
11.6.4. Chronic pain management
11.6.5. Parkinson’s disease
11.6.6. Depression
11.6.7. Urinary and fecal incontinence
11.6.8. Gastroparesis
11.6.9. Migraine
11.6.10. Obsessive-compulsive disorder
11.6.11. Others
11.7. North America Internal Neuromodulation Devices Market Value Share Analysis, By End User
11.8. North America Internal Neuromodulation Devices Market Forecast, By End User
11.8.1. Hospitals
11.8.2. Clinics
11.8.3. Home healthcare
11.9. North America Internal Neuromodulation Devices Market Value Share Analysis, By Country
11.10. North America Internal Neuromodulation Devices Market Forecast, By Country
11.10.1. U.S.
11.10.2. Canada
11.10.3. Mexico
11.11. North America Internal Neuromodulation Devices Market Analysis, By Country
11.12. U.S. Internal Neuromodulation Devices Market Forecast, By Product Type
11.12.1. Deep brain stimulators
11.12.2. Sacral nerve stimulators
11.12.3. Vagus nerve stimulators
11.12.4. Spinal cord stimulators
11.12.5. Other internal neuromodulation devices
11.13. U.S. Internal Neuromodulation Devices Market Forecast, By Application
11.13.1. Failed back syndrome
11.13.2. Tremors
11.13.3. Epilepsy
11.13.4. Chronic pain management
11.13.5. Parkinson’s disease
11.13.6. Depression
11.13.7. Urinary and fecal incontinence
11.13.8. Gastroparesis
11.13.9. Migraine
11.13.10. Obsessive-compulsive disorder
11.13.11. Others
11.14. U.S. Internal Neuromodulation Devices Market Forecast, By End User
11.14.1. Hospitals
11.14.2. Clinics
11.14.3. Home healthcare
11.15. Canada Internal Neuromodulation Devices Market Forecast, By Product Type
11.15.1. Deep brain stimulators
11.15.2. Sacral nerve stimulators
11.15.3. Vagus nerve stimulators
11.15.4. Spinal cord stimulators
11.15.5. Other internal neuromodulation devices
11.16. Canada Internal Neuromodulation Devices Market Forecast, By Application
11.16.1. Failed back syndrome
11.16.2. Tremors
11.16.3. Epilepsy
11.16.4. Chronic pain management
11.16.5. Parkinson’s disease
11.16.6. Depression
11.16.7. Urinary and fecal incontinence
11.16.8. Gastroparesis
11.16.9. Migraine
11.16.10. Obsessive-compulsive disorder
11.16.11. Others
11.17. Canada Internal Neuromodulation Devices Market Forecast, By End User
11.17.1. Hospitals
11.17.2. Clinics
11.17.3. Home healthcare
11.18. Mexico Internal Neuromodulation Devices Market Forecast, By Product Type
11.18.1. Deep brain stimulators
11.18.2. Sacral nerve stimulators
11.18.3. Vagus nerve stimulators
11.18.4. Spinal cord stimulators
11.18.5. Other internal neuromodulation devices
11.19. Mexico Internal Neuromodulation Devices Market Forecast, By Application
11.19.1. Failed back syndrome
11.19.2. Tremors
11.19.3. Epilepsy
11.19.4. Chronic pain management
11.19.5. Parkinson’s disease
11.19.6. Depression
11.19.7. Urinary and fecal incontinence
11.19.8. Gastroparesis
11.19.9. Migraine
11.19.10. Obsessive-compulsive disorder
11.19.11. Others
11.20. Mexico Internal Neuromodulation Devices Market Forecast, By End User
11.20.1. Hospitals
11.20.2. Clinics
11.20.3. Home healthcare
11.21. North America Internal Neuromodulation Devices Market Attractiveness Analysis
11.21.1. By Product Type
11.21.2. By Application
11.21.3. By End User
11.22. PEST Analysis
11.23. Key Trends
11.24. Key Developments
12. Europe Internal Neuromodulation Devices Market Analysis
12.1. Key Findings
12.2. Europe Internal Neuromodulation Devices Market Overview
12.3. Europe Internal Neuromodulation Devices Market Value Share Analysis, By Product Type
12.4. Europe Internal Neuromodulation Devices Market Forecast, By Product Type
12.4.1. Deep brain stimulators
12.4.2. Sacral nerve stimulators
12.4.3. Vagus nerve stimulators
12.4.4. Spinal cord stimulators
12.4.5. Other internal neuromodulation devices
12.5. Europe Internal Neuromodulation Devices Market Value Share Analysis, By Application
12.6. Europe Internal Neuromodulation Devices Market Forecast, By Application
12.6.1. Failed back syndrome
12.6.2. Tremors
12.6.3. Epilepsy
12.6.4. Chronic pain management
12.6.5. Parkinson’s disease
12.6.6. Depression
12.6.7. Urinary and fecal incontinence
12.6.8. Gastroparesis
12.6.9. Migraine
12.6.10. Obsessive-compulsive disorder
12.6.11. Others
12.7. Europe Internal Neuromodulation Devices Market Value Share Analysis, By End User
12.8. Europe Internal Neuromodulation Devices Market Forecast, By End User
12.8.1. Hospitals
12.8.2. Clinics
12.8.3. Home healthcare
12.9. Europe Internal Neuromodulation Devices Market Value Share Analysis, By Country
12.10. Europe Internal Neuromodulation Devices Market Forecast, By Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Sweden
12.10.7. CIS countries
12.10.8. Rest of Europe
12.11. Germany Internal Neuromodulation Devices Market Forecast, By Product Type
12.11.1. Deep brain stimulators
12.11.2. Sacral nerve stimulators
12.11.3. Vagus nerve stimulators
12.11.4. Spinal cord stimulators
12.11.5. Other internal neuromodulation devices
12.12. Germany Internal Neuromodulation Devices Market Forecast, By Application
12.12.1. Failed back syndrome
12.12.2. Tremors
12.12.3. Epilepsy
12.12.4. Chronic pain management
12.12.5. Parkinson’s disease
12.12.6. Depression
12.12.7. Urinary and fecal incontinence
12.12.8. Gastroparesis
12.12.9. Migraine
12.12.10. Obsessive-compulsive disorder
12.12.11. Others
12.13. Germany Internal Neuromodulation Devices Market Forecast, By End User
12.13.1. Hospitals
12.13.2. Clinics
12.13.3. Home healthcare
12.14. U.K. Internal Neuromodulation Devices Market Forecast, By Product Type
12.14.1. Deep brain stimulators
12.14.2. Sacral nerve stimulators
12.14.3. Vagus nerve stimulators
12.14.4. Spinal cord stimulators
12.14.5. Other internal neuromodulation devices
12.15. U.K. Internal Neuromodulation Devices Market Forecast, By Application
12.15.1. Failed back syndrome
12.15.2. Tremors
12.15.3. Epilepsy
12.15.4. Chronic pain management
12.15.5. Parkinson’s disease
12.15.6. Depression
12.15.7. Urinary and fecal incontinence
12.15.8. Gastroparesis
12.15.9. Migraine
12.15.10. Obsessive-compulsive disorder
12.15.11. Others
12.16. U.K. Internal Neuromodulation Devices Market Forecast, By End User
12.16.1. Hospitals
12.16.2. Clinics
12.16.3. Home healthcare
12.17. France Internal Neuromodulation Devices Market Forecast, By Product Type
12.17.1. Deep brain stimulators
12.17.2. Sacral nerve stimulators
12.17.3. Vagus nerve stimulators
12.17.4. Spinal cord stimulators
12.17.5. Other internal neuromodulation devices
12.18. France Internal Neuromodulation Devices Market Forecast, By Application
12.18.1. Failed back syndrome
12.18.2. Tremors
12.18.3. Epilepsy
12.18.4. Chronic pain management
12.18.5. Parkinson’s disease
12.18.6. Depression
12.18.7. Urinary and fecal incontinence
12.18.8. Gastroparesis
12.18.9. Migraine
12.18.10. Obsessive-compulsive disorder
12.18.11. Others
12.19. France Internal Neuromodulation Devices Market Forecast, By End User
12.19.1. Hospitals
12.19.2. Clinics
12.19.3. Home healthcare
12.20. Italy Internal Neuromodulation Devices Market Forecast, By Product Type
12.20.1. Deep brain stimulators
12.20.2. Sacral nerve stimulators
12.20.3. Vagus nerve stimulators
12.20.4. Spinal cord stimulators
12.20.5. Other internal neuromodulation devices
12.21. Italy Internal Neuromodulation Devices Market Forecast, By Application
12.21.1. Failed back syndrome
12.21.2. Tremors
12.21.3. Epilepsy
12.21.4. Chronic pain management
12.21.5. Parkinson’s disease
12.21.6. Depression
12.21.7. Urinary and fecal incontinence
12.21.8. Gastroparesis
12.21.9. Migraine
12.21.10. Obsessive-compulsive disorder
12.21.11. Others
12.22. Italy Internal Neuromodulation Devices Market Forecast, By End User
12.22.1. Hospitals
12.22.2. Clinics
12.22.3. Home healthcare
12.23. Spain Internal Neuromodulation Devices Market Forecast, By Product Type
12.23.1. Deep brain stimulators
12.23.2. Sacral nerve stimulators
12.23.3. Vagus nerve stimulators
12.23.4. Spinal cord stimulators
12.23.5. Other internal neuromodulation devices
12.24. Spain Internal Neuromodulation Devices Market Forecast, By Application
12.24.1. Failed back syndrome
12.24.2. Tremors
12.24.3. Epilepsy
12.24.4. Chronic pain management
12.24.5. Parkinson’s disease
12.24.6. Depression
12.24.7. Urinary and fecal incontinence
12.24.8. Gastroparesis
12.24.9. Migraine
12.24.10. Obsessive-compulsive disorder
12.24.11. Others
12.25. Spain Internal Neuromodulation Devices Market Forecast, By End User
12.25.1. Hospitals
12.25.2. Clinics
12.25.3. Home healthcare
12.26. Sweden Internal Neuromodulation Devices Market Forecast, By Product Type
12.26.1. Deep brain stimulators
12.26.2. Sacral nerve stimulators
12.26.3. Vagus nerve stimulators
12.26.4. Spinal cord stimulators
12.26.5. Other internal neuromodulation devices
12.27. Sweden Internal Neuromodulation Devices Market Forecast, By Application
12.27.1. Failed back syndrome
12.27.2. Tremors
12.27.3. Epilepsy
12.27.4. Chronic pain management
12.27.5. Parkinson’s disease
12.27.6. Depression
12.27.7. Urinary and fecal incontinence
12.27.8. Gastroparesis
12.27.9. Migraine
12.27.10. Obsessive-compulsive disorder
12.27.11. Others
12.28. Sweden Internal Neuromodulation Devices Market Forecast, By End User
12.28.1. Hospitals
12.28.2. Clinics
12.28.3. Home healthcare
12.29. CIS countries Internal Neuromodulation Devices Market Forecast, By Product Type
12.29.1. Deep brain stimulators
12.29.2. Sacral nerve stimulators
12.29.3. Vagus nerve stimulators
12.29.4. Spinal cord stimulators
12.29.5. Other internal neuromodulation devices
12.30. CIS countries Internal Neuromodulation Devices Market Forecast, By Application
12.30.1. Failed back syndrome
12.30.2. Tremors
12.30.3. Epilepsy
12.30.4. Chronic pain management
12.30.5. Parkinson’s disease
12.30.6. Depression
12.30.7. Urinary and fecal incontinence
12.30.8. Gastroparesis
12.30.9. Migraine
12.30.10. Obsessive-compulsive disorder
12.30.11. Others
12.31. CIS countries Internal Neuromodulation Devices Market Forecast, By End User
12.31.1. Hospitals
12.31.2. Clinics
12.31.3. Home healthcare
12.32. Rest of Europe Internal Neuromodulation Devices Market Forecast, By Product Type
12.32.1. Deep brain stimulators
12.32.2. Sacral nerve stimulators
12.32.3. Vagus nerve stimulators
12.32.4. Spinal cord stimulators
12.32.5. Other internal neuromodulation devices
12.33. Rest of Europe Internal Neuromodulation Devices Market Forecast, By Application
12.33.1. Failed back syndrome
12.33.2. Tremors
12.33.3. Epilepsy
12.33.4. Chronic pain management
12.33.5. Parkinson’s disease
12.33.6. Depression
12.33.7. Urinary and fecal incontinence
12.33.8. Gastroparesis
12.33.9. Migraine
12.33.10. Obsessive-compulsive disorder
12.33.11. Others
12.34. Rest of Europe Internal Neuromodulation Devices Market Forecast, By End User
12.34.1. Hospitals
12.34.2. Clinics
12.34.3. Home healthcare
12.35. Europe Internal Neuromodulation Devices Market Attractiveness Analysis
12.35.1. By Application
12.35.2. By Product Type
12.35.3. By End User
12.36. PEST Analysis
12.37. Key Trends
12.38. Key Developments
13. Asia Pacific Internal Neuromodulation Devices Market Analysis
13.1. Key Findings
13.2. Asia Pacific Internal Neuromodulation Devices Market Overview
13.3. Asia Pacific Internal Neuromodulation Devices Market Value Share Analysis, By Product Type
13.4. Asia Pacific Internal Neuromodulation Devices Market Forecast, By Product Type
13.4.1. Deep brain stimulators
13.4.2. Sacral nerve stimulators
13.4.3. Vagus nerve stimulators
13.4.4. Spinal cord stimulators
13.4.5. Other internal neuromodulation devices
13.5. Asia Pacific Internal Neuromodulation Devices Market Value Share Analysis, By Application
13.6. Asia Pacific Internal Neuromodulation Devices Market Forecast, By Application
13.6.1. Failed back syndrome
13.6.2. Tremors
13.6.3. Epilepsy
13.6.4. Chronic pain management
13.6.5. Parkinson’s disease
13.6.6. Depression
13.6.7. Urinary and fecal incontinence
13.6.8. Gastroparesis
13.6.9. Migraine
13.6.10. Obsessive-compulsive disorder
13.6.11. Others
13.7. Asia Pacific Internal Neuromodulation Devices Market Value Share Analysis, By End User
13.8. Asia Pacific Internal Neuromodulation Devices Market Forecast, By End User
13.8.1. Hospitals
13.8.2. Clinics
13.8.3. Home healthcare
13.9. Asia Pacific Internal Neuromodulation Devices Market Value Share Analysis, By Country
13.10. Asia Pacific Internal Neuromodulation Devices Market Forecast, By Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. South Korea
13.10.5. Australia
13.10.6. ASEAN
13.10.7. Rest of Asia Pacific
13.11. Asia Pacific Internal Neuromodulation Devices Market Analysis, By Country
13.12. China Internal Neuromodulation Devices Market Forecast, By Product Type
13.12.1. Deep brain stimulators
13.12.2. Sacral nerve stimulators
13.12.3. Vagus nerve stimulators
13.12.4. Spinal cord stimulators
13.12.5. Other internal neuromodulation devices
13.13. China Internal Neuromodulation Devices Market Forecast, By Application
13.13.1. Failed back syndrome
13.13.2. Tremors
13.13.3. Epilepsy
13.13.4. Chronic pain management
13.13.5. Parkinson’s disease
13.13.6. Depression
13.13.7. Urinary and fecal incontinence
13.13.8. Gastroparesis
13.13.9. Migraine
13.13.10. Obsessive-compulsive disorder
13.13.11. Others
13.14. China Internal Neuromodulation Devices Market Forecast, By End User
13.14.1. Hospitals
13.14.2. Clinics
13.14.3. Home healthcare
13.15. India Internal Neuromodulation Devices Market Forecast, By Product Type
13.15.1. Deep brain stimulators
13.15.2. Sacral nerve stimulators
13.15.3. Vagus nerve stimulators
13.15.4. Spinal cord stimulators
13.15.5. Other internal neuromodulation devices
13.16. India Internal Neuromodulation Devices Market Forecast, By Application
13.16.1. Failed back syndrome
13.16.2. Tremors
13.16.3. Epilepsy
13.16.4. Chronic pain management
13.16.5. Parkinson’s disease
13.16.6. Depression
13.16.7. Urinary and fecal incontinence
13.16.8. Gastroparesis
13.16.9. Migraine
13.16.10. Obsessive-compulsive disorder
13.16.11. Others
13.17. India Internal Neuromodulation Devices Market Forecast, By End User
13.17.1. Hospitals
13.17.2. Clinics
13.17.3. Home healthcare
13.18. Japan Internal Neuromodulation Devices Market Forecast, By Product Type
13.18.1. Deep brain stimulators
13.18.2. Sacral nerve stimulators
13.18.3. Vagus nerve stimulators
13.18.4. Spinal cord stimulators
13.18.5. Other internal neuromodulation devices
13.19. Japan Internal Neuromodulation Devices Market Forecast, By Application
13.19.1. Failed back syndrome
13.19.2. Tremors
13.19.3. Epilepsy
13.19.4. Chronic pain management
13.19.5. Parkinson’s disease
13.19.6. Depression
13.19.7. Urinary and fecal incontinence
13.19.8. Gastroparesis
13.19.9. Migraine
13.19.10. Obsessive-compulsive disorder
13.19.11. Others
13.20. Japan Internal Neuromodulation Devices Market Forecast, By End User
13.20.1. Hospitals
13.20.2. Clinics
13.20.3. Home healthcare
13.21. South Korea Internal Neuromodulation Devices Market Forecast, By Product Type
13.21.1. Deep brain stimulators
13.21.2. Sacral nerve stimulators
13.21.3. Vagus nerve stimulators
13.21.4. Spinal cord stimulators
13.21.5. Other internal neuromodulation devices
13.22. South Korea Internal Neuromodulation Devices Market Forecast, By Application
13.22.1. Failed back syndrome
13.22.2. Tremors
13.22.3. Epilepsy
13.22.4. Chronic pain management
13.22.5. Parkinson’s disease
13.22.6. Depression
13.22.7. Urinary and fecal incontinence
13.22.8. Gastroparesis
13.22.9. Migraine
13.22.10. Obsessive-compulsive disorder
13.22.11. Others
13.23. South Korea Internal Neuromodulation Devices Market Forecast, By End User
13.23.1. Hospitals
13.23.2. Clinics
13.23.3. Home healthcare
13.24. Australia Internal Neuromodulation Devices Market Forecast, By Product Type
13.24.1. Deep brain stimulators
13.24.2. Sacral nerve stimulators
13.24.3. Vagus nerve stimulators
13.24.4. Spinal cord stimulators
13.24.5. Other internal neuromodulation devices
13.25. Australia Internal Neuromodulation Devices Market Forecast, By Application
13.25.1. Failed back syndrome
13.25.2. Tremors
13.25.3. Epilepsy
13.25.4. Chronic pain management
13.25.5. Parkinson’s disease
13.25.6. Depression
13.25.7. Urinary and fecal incontinence
13.25.8. Gastroparesis
13.25.9. Migraine
13.25.10. Obsessive-compulsive disorder
13.25.11. Others
13.26. Australia Internal Neuromodulation Devices Market Forecast, By End User
13.26.1. Hospitals
13.26.2. Clinics
13.26.3. Home healthcare
13.27. ASEAN Internal Neuromodulation Devices Market Forecast, By Product Type
13.27.1. Deep brain stimulators
13.27.2. Sacral nerve stimulators
13.27.3. Vagus nerve stimulators
13.27.4. Spinal cord stimulators
13.27.5. Other internal neuromodulation devices
13.28. ASEAN Internal Neuromodulation Devices Market Forecast, By Application
13.28.1. Failed back syndrome
13.28.2. Tremors
13.28.3. Epilepsy
13.28.4. Chronic pain management
13.28.5. Parkinson’s disease
13.28.6. Depression
13.28.7. Urinary and fecal incontinence
13.28.8. Gastroparesis
13.28.9. Migraine
13.28.10. Obsessive-compulsive disorder
13.28.11. Others
13.29. ASEAN Internal Neuromodulation Devices Market Forecast, By End User
13.29.1. Hospitals
13.29.2. Clinics
13.29.3. Home healthcare
13.30. Rest of Asia Pacific Internal Neuromodulation Devices Market Forecast, By Product Type
13.30.1. Deep brain stimulators
13.30.2. Sacral nerve stimulators
13.30.3. Vagus nerve stimulators
13.30.4. Spinal cord stimulators
13.30.5. Other internal neuromodulation devices
13.31. Rest of Asia Pacific Internal Neuromodulation Devices Market Forecast, By Application
13.31.1. Failed back syndrome
13.31.2. Tremors
13.31.3. Epilepsy
13.31.4. Chronic pain management
13.31.5. Parkinson’s disease
13.31.6. Depression
13.31.7. Urinary and fecal incontinence
13.31.8. Gastroparesis
13.31.9. Migraine
13.31.10. Obsessive-compulsive disorder
13.31.11. Others
13.32. Rest of Asia Pacific Internal Neuromodulation Devices Market Forecast, By End User
13.32.1. Hospitals
13.32.2. Clinics
13.32.3. Home healthcare
13.33. Asia Pacific Internal Neuromodulation Devices Market Attractiveness Analysis
13.33.1. By Product Type
13.33.2. By Application
13.33.3. By End User
13.34. PEST Analysis
13.35. Key Trends
13.36. Key Developments
14. Middle East & Africa Internal Neuromodulation Devices Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Internal Neuromodulation Devices Market Overview
14.3. Middle East & Africa Internal Neuromodulation Devices Market Value Share Analysis, By Product Type
14.4. Middle East & Africa Internal Neuromodulation Devices Market Forecast, By Product Type
14.4.1. Deep brain stimulators
14.4.2. Sacral nerve stimulators
14.4.3. Vagus nerve stimulators
14.4.4. Spinal cord stimulators
14.4.5. Other internal neuromodulation devices
14.5. Middle East & Africa Internal Neuromodulation Devices Market Value Share Analysis, By Application
14.6. Middle East & Africa Internal Neuromodulation Devices Market Forecast, By Application
14.6.1. Failed back syndrome
14.6.2. Tremors
14.6.3. Epilepsy
14.6.4. Chronic pain management
14.6.5. Parkinson’s disease
14.6.6. Depression
14.6.7. Urinary and fecal incontinence
14.6.8. Gastroparesis
14.6.9. Migraine
14.6.10. Obsessive-compulsive disorder
14.6.11. Others
14.7. Middle East & Africa Internal Neuromodulation Devices Market Value Share Analysis, By End User
14.8. Middle East & Africa Internal Neuromodulation Devices Market Forecast, By End User
14.8.1. Hospitals
14.8.2. Clinics
14.8.3. Home healthcare
14.9. Middle East & Africa Internal Neuromodulation Devices Market Value Share Analysis, By Country
14.10. Middle East & Africa Internal Neuromodulation Devices Market Forecast, By Country
14.10.1. GCC Countries
14.10.2. South Africa
14.10.3. Nigeria
14.10.4. Egypt
14.10.5. Rest of Middle East & Africa
14.11. Middle East & Africa Internal Neuromodulation Devices Market Analysis, By Country
14.12. GCC Countries Internal Neuromodulation Devices Market Forecast, By Product Type
14.12.1. Deep brain stimulators
14.12.2. Sacral nerve stimulators
14.12.3. Vagus nerve stimulators
14.12.4. Spinal cord stimulators
14.12.5. Other internal neuromodulation devices
14.13. GCC Countries Internal Neuromodulation Devices Market Forecast, By Application
14.13.1. Failed back syndrome
14.13.2. Tremors
14.13.3. Epilepsy
14.13.4. Chronic pain management
14.13.5. Parkinson’s disease
14.13.6. Depression
14.13.7. Urinary and fecal incontinence
14.13.8. Gastroparesis
14.13.9. Migraine
14.13.10. Obsessive-compulsive disorder
14.13.11. Others
14.14. GCC Countries Internal Neuromodulation Devices Market Forecast, By End User
14.14.1. Hospitals
14.14.2. Clinics
14.14.3. Home healthcare
14.15. South Africa Internal Neuromodulation Devices Market Forecast, By Product Type
14.15.1. Deep brain stimulators
14.15.2. Sacral nerve stimulators
14.15.3. Vagus nerve stimulators
14.15.4. Spinal cord stimulators
14.15.5. Other internal neuromodulation devices
14.16. South Africa Internal Neuromodulation Devices Market Forecast, By Application
14.16.1. Failed back syndrome
14.16.2. Tremors
14.16.3. Epilepsy
14.16.4. Chronic pain management
14.16.5. Parkinson’s disease
14.16.6. Depression
14.16.7. Urinary and fecal incontinence
14.16.8. Gastroparesis
14.16.9. Migraine
14.16.10. Obsessive-compulsive disorder
14.16.11. Others
14.17. South Africa Internal Neuromodulation Devices Market Forecast, By End User
14.17.1. Hospitals
14.17.2. Clinics
14.17.3. Home healthcare
14.18. Nigeria Internal Neuromodulation Devices Market Forecast, By Product Type
14.18.1. Deep brain stimulators
14.18.2. Sacral nerve stimulators
14.18.3. Vagus nerve stimulators
14.18.4. Spinal cord stimulators
14.18.5. Other internal neuromodulation devices
14.19. Nigeria Internal Neuromodulation Devices Market Forecast, By Application
14.19.1. Failed back syndrome
14.19.2. Tremors
14.19.3. Epilepsy
14.19.4. Chronic pain management
14.19.5. Parkinson’s disease
14.19.6. Depression
14.19.7. Urinary and fecal incontinence
14.19.8. Gastroparesis
14.19.9. Migraine
14.19.10. Obsessive-compulsive disorder
14.19.11. Others
14.20. Nigeria Internal Neuromodulation Devices Market Forecast, By End User
14.20.1. Hospitals
14.20.2. Clinics
14.20.3. Home healthcare
14.21. Egypt Internal Neuromodulation Devices Market Forecast, By Product Type
14.21.1. Deep brain stimulators
14.21.2. Sacral nerve stimulators
14.21.3. Vagus nerve stimulators
14.21.4. Spinal cord stimulators
14.21.5. Other internal neuromodulation devices
14.22. Egypt Internal Neuromodulation Devices Market Forecast, By Application
14.22.1. Failed back syndrome
14.22.2. Tremors
14.22.3. Epilepsy
14.22.4. Chronic pain management
14.22.5. Parkinson’s disease
14.22.6. Depression
14.22.7. Urinary and fecal incontinence
14.22.8. Gastroparesis
14.22.9. Migraine
14.22.10. Obsessive-compulsive disorder
14.22.11. Others
14.23. Egypt Internal Neuromodulation Devices Market Forecast, By End User
14.23.1. Hospitals
14.23.2. Clinics
14.23.3. Home healthcare
14.24. Rest of Middle East & Africa Internal Neuromodulation Devices Market Forecast, By Product Type
14.24.1. Deep brain stimulators
14.24.2. Sacral nerve stimulators
14.24.3. Vagus nerve stimulators
14.24.4. Spinal cord stimulators
14.24.5. Other internal neuromodulation devices
14.25. Rest of Middle East & Africa Internal Neuromodulation Devices Market Forecast, By Application
14.25.1. Failed back syndrome
14.25.2. Tremors
14.25.3. Epilepsy
14.25.4. Chronic pain management
14.25.5. Parkinson’s disease
14.25.6. Depression
14.25.7. Urinary and fecal incontinence
14.25.8. Gastroparesis
14.25.9. Migraine
14.25.10. Obsessive-compulsive disorder
14.25.11. Others
14.26. Rest of Middle East & Africa Internal Neuromodulation Devices Market Forecast, By End User
14.26.1. Hospitals
14.26.2. Clinics
14.26.3. Home healthcare
14.27. Middle East & Africa Internal Neuromodulation Devices Market Attractiveness Analysis
14.27.1. By Product Type
14.27.2. By Application
14.27.3. By End User
14.28. PEST Analysis
14.29. Key Trends
14.30. Key Developments
15. South America Internal Neuromodulation Devices Market Analysis
15.1. Key Findings
15.2. South America Internal Neuromodulation Devices Market Overview
15.3. South America Internal Neuromodulation Devices Market Value Share Analysis, By Product Type
15.4. South America Internal Neuromodulation Devices Market Forecast, By Product Type
15.4.1. Deep brain stimulators
15.4.2. Sacral nerve stimulators
15.4.3. Vagus nerve stimulators
15.4.4. Spinal cord stimulators
15.4.5. Other internal neuromodulation devices
15.5. South America Internal Neuromodulation Devices Market Value Share Analysis, By Application
15.6. South America Internal Neuromodulation Devices Market Forecast, By Application
15.6.1. Failed back syndrome
15.6.2. Tremors
15.6.3. Epilepsy
15.6.4. Chronic pain management
15.6.5. Parkinson’s disease
15.6.6. Depression
15.6.7. Urinary and fecal incontinence
15.6.8. Gastroparesis
15.6.9. Migraine
15.6.10. Obsessive-compulsive disorder
15.6.11. Others
15.7. South America Internal Neuromodulation Devices Market Value Share Analysis, By End User
15.8. South America Internal Neuromodulation Devices Market Forecast, By End User
15.8.1. Hospitals
15.8.2. Clinics
15.8.3. Home healthcare
15.9. South America Internal Neuromodulation Devices Market Value Share Analysis, By Country
15.10. South America Internal Neuromodulation Devices Market Forecast, By Country
15.10.1. Brazil
15.10.2. Colombia
15.10.3. Argentina
15.10.4. Rest of South America
15.11. South America Internal Neuromodulation Devices Market Analysis, By Country
15.12. Brazil Internal Neuromodulation Devices Market Forecast, By Product Type
15.12.1. Deep brain stimulators
15.12.2. Sacral nerve stimulators
15.12.3. Vagus nerve stimulators
15.12.4. Spinal cord stimulators
15.12.5. Other internal neuromodulation devices
15.13. Brazil Internal Neuromodulation Devices Market Forecast, By Application
15.13.1. Failed back syndrome
15.13.2. Tremors
15.13.3. Epilepsy
15.13.4. Chronic pain management
15.13.5. Parkinson’s disease
15.13.6. Depression
15.13.7. Urinary and fecal incontinence
15.13.8. Gastroparesis
15.13.9. Migraine
15.13.10. Obsessive-compulsive disorder
15.13.11. Others
15.14. Brazil Internal Neuromodulation Devices Market Forecast, By End User
15.14.1. Hospitals
15.14.2. Clinics
15.14.3. Home healthcare
15.15. Colombia Internal Neuromodulation Devices Market Forecast, By Product Type
15.15.1. Deep brain stimulators
15.15.2. Sacral nerve stimulators
15.15.3. Vagus nerve stimulators
15.15.4. Spinal cord stimulators
15.15.5. Other internal neuromodulation devices
15.16. Colombia Internal Neuromodulation Devices Market Forecast, By Application
15.16.1. Failed back syndrome
15.16.2. Tremors
15.16.3. Epilepsy
15.16.4. Chronic pain management
15.16.5. Parkinson’s disease
15.16.6. Depression
15.16.7. Urinary and fecal incontinence
15.16.8. Gastroparesis
15.16.9. Migraine
15.16.10. Obsessive-compulsive disorder
15.16.11. Others
15.17. Colombia Internal Neuromodulation Devices Market Forecast, By End User
15.17.1. Hospitals
15.17.2. Clinics
15.17.3. Home healthcare
15.18. Argentina Internal Neuromodulation Devices Market Forecast, By Product Type
15.18.1. Deep brain stimulators
15.18.2. Sacral nerve stimulators
15.18.3. Vagus nerve stimulators
15.18.4. Spinal cord stimulators
15.18.5. Other internal neuromodulation devices
15.19. Argentina Internal Neuromodulation Devices Market Forecast, By Application
15.19.1. Failed back syndrome
15.19.2. Tremors
15.19.3. Epilepsy
15.19.4. Chronic pain management
15.19.5. Parkinson’s disease
15.19.6. Depression
15.19.7. Urinary and fecal incontinence
15.19.8. Gastroparesis
15.19.9. Migraine
15.19.10. Obsessive-compulsive disorder
15.19.11. Others
15.20. Argentina Internal Neuromodulation Devices Market Forecast, By End User
15.20.1. Hospitals
15.20.2. Clinics
15.20.3. Home healthcare
15.21. Rest of South America Internal Neuromodulation Devices Market Forecast, By Product Type
15.21.1. Deep brain stimulators
15.21.2. Sacral nerve stimulators
15.21.3. Vagus nerve stimulators
15.21.4. Spinal cord stimulators
15.21.5. Other internal neuromodulation devices
15.22. Rest of South America Internal Neuromodulation Devices Market Forecast, By Application
15.22.1. Failed back syndrome
15.22.2. Tremors
15.22.3. Epilepsy
15.22.4. Chronic pain management
15.22.5. Parkinson’s disease
15.22.6. Depression
15.22.7. Urinary and fecal incontinence
15.22.8. Gastroparesis
15.22.9. Migraine
15.22.10. Obsessive-compulsive disorder
15.22.11. Others
15.23. Rest of South America Internal Neuromodulation Devices Market Forecast, By End User
15.23.1. Hospitals
15.23.2. Clinics
15.23.3. Home healthcare
15.24. South America Internal Neuromodulation Devices Market Attractiveness Analysis
15.24.1. By Product Type
15.24.2. By Application
15.24.3. By End User
15.25. PEST Analysis
15.26. Key Trends
15.27. Key Developments
16. Company Profiles
16.1. Market Share Analysis, By Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players By price, presence, market share, Component, and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A By Regions, Investment and Component
16.2.3.2. M&A Key Players, Forward Integration and Backward Integration
16.3. Company Profiles: Key Players
16.3.1. Medtronic plc
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Development Footprint
16.3.2. LivaNova PLC
16.3.3. Cyberonics Inc.
16.3.4. St. Jude Medical Inc.
16.3.5. Boston Scientific Corporation
16.3.6. EnteroMedics Inc
16.3.7. BioControl Medical
16.3.8. Bioness Inc.
16.3.9. Nevro Corporation
16.3.10. NeuroPace Inc.
16.3.11. Abbott
16.3.12. Synapse Biomedical
16.3.13. Neurosigma
16.3.14. Neuronetics
16.3.15. Soterix Medical
16.3.16. Integer Holdings Corporation
16.3.17. Bioinduction
16.3.18. GiMer Medical
16.3.19. GTX Medical
16.3.20. Helius Medical Technologies
16.3.21. Micro transponder
16.3.22. Neuronano
16.3.23. Bluewind
17. Primary key Insights